Lane Labs BeneFin Is Unapproved Drug - FDA Complaint
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking a permanent injunction against the sale of Lane Labs-USA's BeneFin, SkinAnswer and MGN-3 products, alleging they are "unapproved drugs" and "illegally promoted as treatments for cancer and other diseases."